Xeris Biopharma Holdings Inc. Common Stock (XERS)

Stock · NASDAQ · Health Care

$8.48as of 8/28/2026

Price chart

Insider transactionsShow all transaction typesRevenue Growth

No technical signal is currently active for this symbol.

Support level

$6.17

Industry

Biotechnology: Pharmaceutical Preparations

Chosen by industry and closest market cap.

XERS
Xeris Biopharma Holdings Inc. Common Stock
$8.48
▼ 1.40%
Market cap $1.40BP/E —
AVBP
ArriVent BioPharma Inc. Common Stock
$30.19
▼ 2.63%
Market cap $1.38BP/E —
$17$35.83
XNCR
Xencor Inc. Common Stock
$26.06
▼ 9.76%
Market cap $1.44BP/E —
$7.8$30.61
HROW
Harrow Inc. Common Stock
$37.23
▼ 3.40%
Market cap $1.46BP/E —
$28.54$54.85
PAHC
Phibro Animal Health Corporation Class A Common Stock
$37.64
▲ 3.55%
Market cap $1.51BP/E 14.51
$28.25$60.08
INVA
Innoviva Inc. Common Stock
$20.97
▲ 0.05%
Market cap $1.53BP/E 4.21
$16.52$25.15
AAPG
Ascentage Pharma Group International American Depository Shares
$18.28
▼ 2.16%
Market cap $1.57BP/E —
$30$91.5

Symbol	Market cap	P/E ratio	Price	1D	52-week range
XERS Xeris Biopharma Holdings Inc. Common Stock	$1.40B	—	$8.48	▼ 1.40%
AVBP ArriVent BioPharma Inc. Common Stock	$1.38B	—	$30.19	▼ 2.63%	$17$35.83
XNCR Xencor Inc. Common Stock	$1.44B	—	$26.06	▼ 9.76%	$7.8$30.61
HROW Harrow Inc. Common Stock	$1.46B	—	$37.23	▼ 3.40%	$28.54$54.85
PAHC Phibro Animal Health Corporation Class A Common Stock	$1.51B	14.51	$37.64	▲ 3.55%	$28.25$60.08
INVA Innoviva Inc. Common Stock	$1.53B	4.21	$20.97	▲ 0.05%	$16.52$25.15
AAPG Ascentage Pharma Group International American Depository Shares	$1.57B	—	$18.28	▼ 2.16%	$30$91.5

P/E shows — for peers not currently carrying a live signal of their own.

March 31, 2026

Top holders this quarter

See the full, filterable feed with live charts on the MarketWall dashboard.